Research
Myrrh
13 peer-reviewed studies curated from PubMed and Semantic Scholar.
Studies
Sorted by quality and recency
Efficacy of Myrrh in the treatment of schistosomiasis (haematobium and mansoni) in Ezbet El-Bakly, Tamyia Center, El-Fayoum Governorate, Egypt.
Field survey in Ezbet El-Bakly, Egypt, evaluating the efficacy of Mirazid (myrrh extract) in treating schistosomiasis haematobium and mansoni. Among 1019 individuals, the parasitological cure rate after three months was 97.4% for S. haematobium and 96.2% for S. mansoni, with no side effects reported.
Clinical trial of Mirazid in treatment of human fascioliasis, Ezbet El-Bakly (Tamyia Center) Al-Fayoum Governorate.
A field survey in Ezbet El-Bakly, Egypt assessed the efficacy and safety of Mirazid (Myrrh extract) in treating human fascioliasis. The study found a parasitological cure rate of 88.2% and 94.1% two and three months after treatment, respectively, with no side effects.
A 12 week, randomized, double-blind, placebo-controlled clinical trial for the evaluation of the efficacy and safety of HT083 on mild osteoarthritis.
This is a 12-week randomized, double-blind, placebo-controlled clinical trial evaluating the efficacy and safety of HT083, a herbal formula composed of Paeonia lactiflora root and Commiphora myrrha gum resin extracts, in 100 patients with mild osteoarthritis. The study aims to assess the treatment's effects on joint pain and inflammation using various health and personal evaluation scales.
Episiotomy wound healing by Commiphora myrrha (Nees) Engl. and Boswellia carteri Birdw. in primiparous women: A randomized controlled trial.
RCT on 90 primiparous women comparing sitz-baths of myrrh extract, frankincense extract, and betadine for episiotomy wound healing. Myrrh showed significantly greater improvement in wound healing compared to frankincense and betadine.
Efficacy and safety of myrrh in patients with incomplete abortion: a randomized, double-blind, placebo-controlled clinical study.
RCT of 80 patients with incomplete abortion comparing 500 mg Myrrh oleo-gum-resin capsules to placebo three times a day for 2 weeks. Myrrh significantly reduced the mean diameter of retained products of conception and increased the rate of successful complete abortion compared to placebo, with no serious adverse effects reported.
A safe, effective, herbal antischistosomal therapy derived from myrrh.
RCT on 204 patients with schistosomiasis using myrrh at 10 mg/kg/day for three days, achieving a cure rate of 91.7%. Re-treatment increased the overall cure rate to 98.09%. The treatment was well tolerated with mild and transient side effects.
Evaluating Soft Tissue Healing after Implant Placement Using Two Different Mouthwashes (Myrrh and Chlorhexidine Gluconate): A Randomized Control Trial.
A double-blind, randomized clinical study evaluated the efficacy of myrrh and chlorhexidine gluconate mouthwashes on postoperative pain and tissue effects after dental implant placement in 35 patients. The study found no statistically significant difference in postoperative swelling, pain, bleeding, and redness between the groups, but myrrh showed a positive impact on wound healing in the acute phase.
Distinct patterns of short-chain fatty acids during flare in patients with ulcerative colitis under treatment with mesalamine or a herbal combination of myrrh, chamomile flowers, and coffee charcoal: secondary analysis of a randomized controlled trial.
This study evaluated the pattern of short-chain fatty acids in ulcerative colitis patients during flare treated with either mesalamine or a herbal preparation of myrrh, chamomile flowers, and coffee charcoal. The herbal preparation group did not show a significant decline in short-chain fatty acids during flare, unlike the mesalamine group.
Hibiscus extract, vegetable proteases and Commiphora myrrha are useful to prevent symptomatic UTI episode in patients affected by recurrent uncomplicated urinary tract infections.
Phase II clinical trial evaluating the efficacy of a combination of Hibiscus extract, vegetable proteases, and Commiphora myrrha extract in preventing symptomatic episodes in women with recurrent urinary tract infections. The treatment reduced the median number of UTIs and improved quality of life in a significant number of participants.
A Pilot Study on Bioactive Constituents and Analgesic Effects of MyrLiq®, aExtract with a High Furanodiene Content.
RCT evaluating the analgesic effects of MyrLiq, a myrrh extract with high furanodiene content, in 184 volunteers with various pain pathologies. Significant pain alleviation was observed with 400 mg/day in males and 200 mg/day in females for specific pain types.
Randomised clinical trial: a herbal preparation of myrrh, chamomile and coffee charcoal compared with mesalazine in maintaining remission in ulcerative colitis--a double-blind, double-dummy study.
Randomised, double-blind, double-dummy study comparing a herbal preparation of myrrh, chamomile extract, and coffee charcoal to mesalazine in maintaining remission in ulcerative colitis over 12 months. The herbal preparation showed no significant difference in efficacy compared to mesalazine, with good safety and tolerability.
Efficacy of myrrh in the treatment of human Schistosomiasis mansoni.
RCT assessing the efficacy of myrrh (Mirazid) as an antischistosomal treatment in 104 individuals infected with Schistosoma mansoni. The cure rate with myrrh was very low, with 15.6% after the first treatment and 8.9% after the second treatment, raising doubts about its antischistosomal properties.
Preliminary study of therapeutic efficacy of a new fasciolicidal drug derived from Commiphora molmol (myrrh).
Preliminary study of myrrh (Commiphora molmol) for treating fascioliasis in 7 patients. Myrrh was administered at 12 mg/kg per day for 6 days, resulting in a dramatic drop in Fasciola egg count and improvement in symptoms. No toxicity or adverse effects were observed.